Cargando…
A rare case of neuroleptic malignant syndrome without elevated serum creatine kinase
Neuroleptic malignant syndrome (NMS) is a life-threatening adverse reaction to antipsychotic drugs. Although there is no specific examination able to diagnose NMS, serum creatine kinase (CK) elevation has been reported in over 90% of NMS patients. In this report, we describe a patient who developed...
Autores principales: | Nisijima, Koichi, Shioda, Katutoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938441/ https://www.ncbi.nlm.nih.gov/pubmed/24591835 http://dx.doi.org/10.2147/NDT.S58677 |
Ejemplares similares
-
Temporal changes in serum creatine kinase concentration and degree of muscle rigidity in 24 patients with neuroleptic malignant syndrome
por: Nisijima, Koichi, et al.
Publicado: (2013) -
Elevated creatine kinase does not necessarily correspond temporally with onset of muscle rigidity in neuroleptic malignant syndrome: a report of two cases
por: Nisijima, Koichi
Publicado: (2012) -
Neuroleptic Malignant Syndrome Improved with Intramuscular Administration of the Anticholinergic Agent, Biperiden
por: Nisijima, Koichi
Publicado: (2023) -
Exceptionally high creatine kinase levels in risperidone-induced neuroleptic malignant syndrome: A case report
por: Ozaal, Siddiqa, et al.
Publicado: (2022) -
Neuroleptic malignant-like syndrome with a slight elevation of creatine-kinase levels and respiratory failure in a patient with Parkinson’s disease
por: Wei, Li, et al.
Publicado: (2014)